Skip to main content

Advertisement

Log in

Children’s views on unlicensed/off-label paediatric prescribing and paediatric clinical trials

  • Clinical Trial
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Objectives

To explore the views and perspectives of children on the unlicensed/off-label use of medicines in children and on the participation of children in clinical trials.

Methods

Focus-group discussions, involving school children, were carried out in a range of primary and secondary schools in Northern Ireland. A purposeful sample was chosen to facilitate representation of various socioeconomic groupings.

Results

A total of 123 pupils, aged from 10 to 16 years, from six schools, participated in 16 focus groups. In general, pupils viewed the unlicensed/off-label use of medicines in children as unsafe and unethical and felt it is necessary to test medicines in children to improve the availability of licensed products. The majority felt that older children should be told, and that parents should be told, about the unlicensed/off-label use of medicines in children, yet they recognised some implications of this, such as potential medication non-adherence.

Conclusions

This is the first study to explore the views of healthy children on unlicensed medicine use in children. Children were able to recognise potential risks associated with the unlicensed use of medicines and felt it is necessary to test and license more medicines in children.

Practice implications

Health care professionals should consider the views of children in decisions that affect their health.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Explore related subjects

Discover the latest articles, news and stories from top researchers in related subjects.

Reference

  1. Shah SS, Hall M, Goodman DM et al (2007) Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med 161:282–290

    Article  PubMed  Google Scholar 

  2. Stewart D, Rouf A, Snaith A et al (2007) Attitudes and experiences of community pharmacists towards paediatric off-label prescribing: a prospective survey. Br J Clin Pharmacol 64:90–95

    Article  PubMed  Google Scholar 

  3. Lindell-Osuagwu L, Korhonen MJ, Saano S et al (2009) Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J Clin Pharm Ther 34:277–287

    Article  PubMed  CAS  Google Scholar 

  4. Pandolfini C, Bonati M (2005) A literature review on off-label drug use in children. Eur J Pediatr 164:552–558

    Article  PubMed  Google Scholar 

  5. Horen B, Montastruc JL, Lapeyre-Mestre M (2002) Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol 54:665–670

    Article  PubMed  Google Scholar 

  6. Ufer M, Kimland E, Bergman U (2004) Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol Drug Saf 13:147–152

    Article  PubMed  Google Scholar 

  7. Turner S, Nunn AJ, Fielding K, Choonara I (1999) Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr 88:965–968

    Article  PubMed  CAS  Google Scholar 

  8. Neubert A, Dormann H, Weiss J et al (2004) The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf 27:1059–1067

    Article  PubMed  Google Scholar 

  9. Sammons H (2009) Ethical issues of clinical trials in children: a European perspective. Arch Dis Child 94:474–477

    Article  PubMed  CAS  Google Scholar 

  10. EEC (2006) Regulation (EC) No 1901 / 2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768 / 92, Directive 2001 / 20 / EC, Directive 2001 / 83 / EC and Regulation (EC) No 726 / 2004. Off J Eur Union 378:1–19

  11. Chappuy H, Doz F, Blanche S et al (2008) Children's views on their involvement in clinical research. Pediatr Blood Cancer 50:1043–1046

    Article  PubMed  Google Scholar 

  12. Chappuy H, Doz F, Blanche S et al (2006) Parental consent in paediatric clinical research. Arch Dis Child 91:112–116

    Article  PubMed  CAS  Google Scholar 

  13. Braun V, Clarke V (2006) Using thematic analysis in psycology. Qual Res Psychol 3:77–101

    Article  Google Scholar 

  14. Pope C, Ziebland S, Mays N (2000) Qualitative research in health care. Analysing qualitative data. BMJ 320:114–116

    Article  PubMed  CAS  Google Scholar 

  15. Barbour RS (2001) Checklists for improving rigour in qualitative research: a case of the tail wagging the dog? BMJ 322:1115–1117

    Article  PubMed  CAS  Google Scholar 

  16. Morgan M, Gibbs S, Maxwell K et al (2002) Hearing children’s voices: methodological issues in conducting focus groups with children aged 7–11 years. Qual Res 2:5–20

    Article  Google Scholar 

  17. Bush PJ, Davidson FR (1982) Medicines and "drugs": what do children think? Health Educ Q 9:209–2024

    Article  PubMed  CAS  Google Scholar 

  18. Menacker F, Aramburuzabala P, Minian N et al (1999) Children and medicines: what they want to know and how they want to learn. J Soc Adm Pharm 16:38–52

    Google Scholar 

  19. Darbyshire P, MacDougall C, Schiller W (2005) Multiple methods in qualitative research with children: more insight or just more? Qual Res 5:417–436

    Article  Google Scholar 

  20. Trakas DJ (ed) (2009) Focus groups revisited: lessons from qualitative research with children. LIT, Berlin

    Google Scholar 

  21. Almarsdottir AB, Zimmer C (1998) Children’s knowledge about medicines. Child Glob J Child Res 5:265–281

    Article  Google Scholar 

  22. Bush PJ, Iannotti RJ, Davidson FR (1982) A longitudinal study of children and medicines. In: Breimer DD, Speiser P (eds) Topics in pharmaceutical sciences. Elsevier, New York

    Google Scholar 

  23. Trakas DJ, Sanz E (eds) (1992) Studying childhood and medicine use, a multidisciplinary approach. ZHTA Medical, Athens

    Google Scholar 

  24. Trakas D, Sanz E (eds) (1996) Childhood and medicine use in a cross-cultural perspective: a European concerted action. Report EUR 16646 EN. European Commission, Brussels

  25. De Maria C, Lussie MT, Bajcar J (2011) What do children know about medications? A review of the literature to guide clinical practice. Can Fam Physician 57:291–295

    PubMed  Google Scholar 

  26. Cherrill J, Hudson H, Cocking C et al (2010) Clinical trials: the viewpoint of children with a chronic illness compared to healthy children. Arch Dis Child 19:229–232

    Article  Google Scholar 

  27. Tait AR, Voepel-Lewis T, Malviya S (2003) Do they understand? (part II): assent of children participating in clinical anesthesia and surgery research. Anesthesiology 98:609–614

    Article  PubMed  Google Scholar 

  28. Ondrusek N, Abramovitch R, Pencharz P, Koren G (1998) Empirical examination of the ability of children to consent to clinical research. J Med Ethics 24:158–165

    Article  PubMed  CAS  Google Scholar 

  29. Mukattash TL, Millership JS, Collier PS, McElnay JC (2008) Public awareness and views on unlicensed use of medicines in children. Br J Clin Pharmacol 66:838–845

    Article  PubMed  CAS  Google Scholar 

  30. Young FE (1989) It's time to talk about children's medications. Questa 23:44–46

    Google Scholar 

  31. Zachry WM, Ginsburg DB (2001) Patient autonomy and the regulation of direct-to-consumer advertising. Clin Ther 23:2024–2037

    Article  PubMed  Google Scholar 

  32. Cherrill J, Hudson H, Cocking C et al (2007) Clinical trials: the viewpoint of children. Arch Dis Child 92:712–713

    Article  PubMed  CAS  Google Scholar 

  33. Wendler D, Jenkins T (2008) Children's and their parents' views on facing research risks for the benefit of others. Arch Pediatr Adolesc Med 162:9–14

    Article  PubMed  Google Scholar 

  34. Wolthers OD (2006) A questionnaire on factors influencing children's assent and dissent to nontherapeutic research. J Med Ethics 32: 292–297

    Google Scholar 

  35. Balen R, Blyth E, Calabretto H, Fraser C, Horrocks C, Manby M (2006) Involving children in health and social research: ‘human becomings’ or ‘active beings’? Childhood 13:29–48

    Article  Google Scholar 

  36. Garcia M, Sanz E, Aramburuzabala P et al (1996) Concepts of adverse drug reactions among children in eight countries. In: Bush PJ, Trakas DJ, Sanz E (eds) Children, medicines, and culture. Pharmaceutical Products Press, New York

    Google Scholar 

  37. Britten N, Ukoumunne OC, Boulton MG (2002) Patients’ attitudes to medicines and expectations for prescriptions. Health Expect 5:256–269

    Article  PubMed  Google Scholar 

  38. Townsend A, Hunt K, Wyke S (2003) Managing multiple morbidity in mid-life: a qualitative study of attitudes to drug use. BMJ 327:837–841

    Article  PubMed  Google Scholar 

  39. John T, Hope T, Savulescu J et al (2008) Children's consent and paediatric research: is it appropriate for healthy children to be the decision-makers in clinical research? Arch Dis Child 93:379–383

    Article  PubMed  CAS  Google Scholar 

  40. Weithorn LA, Campbell SB (1982) The competency of children and adolescents to make informed treatment decisions. Child Dev 53:1589–1598

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

We gratefully thank all children who took part in the focus-group discussions and all teachers who facilitated the research.

Competing interests

None declared.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James C. McElnay.

Additional information

An abstract on this research work was presented at the British Pharmaceutical Conference, 2008.

Appendix 1

Appendix 1

All slides simply contained a title and pictures (Table 3). The researcher, using terminology appropriate to age, explained the process of drug discovery, animal testing and testing in man before medicinal products are licensed and released on to the market. He then explained that some medicines are not tested and licensed for use in children and raised the question of dosage selection for medicines which were not licensed.

Table 3 Slides used in slide show to explain the discovery and licensing of medicines and the fact that not all medicines are licensed for use in children

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mukattash, T., Trew, K., Hawwa, A.F. et al. Children’s views on unlicensed/off-label paediatric prescribing and paediatric clinical trials. Eur J Clin Pharmacol 68, 141–148 (2012). https://doi.org/10.1007/s00228-011-1110-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-011-1110-8

Keywords

Navigation